Universe Pharmaceuticals INC (NASDAQ:UPC – Get Free Report)’s stock price was down 2.4% on Tuesday . The company traded as low as $3.60 and last traded at $3.60. Approximately 17,931 shares changed hands during mid-day trading, a decline of 35% from the average daily volume of 27,418 shares. The stock had previously closed at $3.69.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Universe Pharmaceuticals in a research report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Universe Pharmaceuticals presently has an average rating of “Sell”.
Read Our Latest Stock Analysis on Universe Pharmaceuticals
Universe Pharmaceuticals Trading Down 2.4%
About Universe Pharmaceuticals
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.
Further Reading
- Five stocks we like better than Universe Pharmaceuticals
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
- What Is WallStreetBets and What Stocks Are They Targeting?
- Strategy Shares Plunge as Bitcoin Retreats—More Pain Ahead?
- What Does a Stock Split Mean?
- BigBear.ai Stock Is Range-Bound—Wall Street Isn’t Buying the Hype
Receive News & Ratings for Universe Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universe Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
